OPSUMIT
Actelion Pharmaceuticals Ltd
Application Filed: 2012-09-13
Trademark Application Details
REGISTERED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 85727907 |
| Registration Number | 4589297 |
| Mark Drawing Code | 3000: Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) |
| Domestic Representative | Cheryl Foytlin |
| Attorney Name | Cheryl Foytlin |
| Attorney Docket Number | T41818US1 |
| Law Office Assigned | L90 |
| Employee Name | LATTUCA, FRANK J |
Timeline
| 2012-09-13 | Application Filed |
| 2012-12-25 | Published for Opposition |
| 2013-11-04 | Date of First Use |
| 2014-07-14 | Location: PUBLICATION AND ISSUE SECTION |
| 2014-08-19 | Status: Live/Registered |
| 2014-08-19 | Trademark Registered |
| 2019-08-19 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Actelion Pharmaceuticals Ltd |
| Address | Gewerbestrasse 16 Allschwil CH CH-4123 |
| Legal Entity Type | Corporation |
| Legal Entity State | CH |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Design Search Codes
| 241502 | Arrows forming any other geometric figure |
| 261712 | Angles (geometric); Chevrons |
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| CC0000 | Color is not claimed as a feature of the mark. |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2012-09-17 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2012-09-18 | 2 NWOS I:Incoming Correspondence |
| NOTICE OF DESIGN SEARCH CODE MAILED | 2012-09-19 | 3 MDSC O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2012-10-17 | 4 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2012-10-22 | 5 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2012-10-22 | 6 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2012-10-22 | 7 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2012-11-02 | 8 TROA I:Incoming Correspondence |
| ASSIGNED TO LIE | 2012-11-13 | 9 ALIE A:Allowance for Publication |
| APPLICANT AMENDMENT PRIOR TO EXAMINATION - ENTERED | 2012-11-20 | 10 AMPX O:Outgoing Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2012-11-20 | 11 CNSA P: |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2012-11-21 | 12 PREV O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2012-12-05 | 13 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2012-12-25 | 14 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2012-12-25 | 15 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2013-02-19 | 16 NOAM E:E-Mail |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2013-05-30 | 17 TCCA I:Incoming Correspondence |
| TEAS EXTENSION RECEIVED | 2013-07-10 | 18 EEXT I:Incoming Correspondence |
| EXTENSION 1 FILED | 2013-07-10 | 19 EXT1 S: |
| EXTENSION 1 GRANTED | 2013-07-10 | 20 EX1G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2013-07-12 | 21 EXRA E:E-Mail |
| TEAS STATEMENT OF USE RECEIVED | 2014-02-14 | 22 EISU I:Incoming Correspondence |
| TEAS EXTENSION RECEIVED | 2014-02-14 | 23 EEXT I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2014-03-02 | 24 AITU A:Allowance for Publication |
| EXTENSION 2 FILED | 2014-02-14 | 25 EXT2 S: |
| EXTENSION 2 GRANTED | 2014-03-04 | 26 EX2G S: |
| USE AMENDMENT FILED | 2014-02-14 | 27 IUAF S: |
| STATEMENT OF USE PROCESSING COMPLETE | 2014-03-04 | 28 SUPC I:Incoming Correspondence |
| SU - NON-FINAL ACTION - WRITTEN | 2014-03-04 | 29 CNRT W: |
| NON-FINAL ACTION E-MAILED | 2014-03-04 | 30 GNRT O:Outgoing Correspondence |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2014-03-04 | 31 GNRN O:Outgoing Correspondence |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2014-03-05 | 32 EXRA E:E-Mail |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2014-06-27 | 33 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2014-07-08 | 34 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2014-07-08 | 35 TEME I:Incoming Correspondence |
| ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2014-07-14 | 36 CNPR P: |
| NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2014-07-15 | 37 SUNA E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2014-08-19 | 38 R.PR A:Allowance for Publication |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2018-03-06 | 39 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2018-03-06 | 40 ARAA I:Incoming Correspondence |
| COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | 2019-08-19 | 41 REM1 E:E-Mail |
| TEAS SECTION 8 & 15 RECEIVED | 2020-08-18 | 42 E815 I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2020-10-06 | 43 APRE A:Allowance for Publication |
| POST REGISTRATION ACTION MAILED - SEC. 8 & 15 | 2020-10-08 | 44 PR23 O:Outgoing Correspondence |
| CANCELLED SEC. 8 (6-YR) | 2021-10-04 | 45 C8.. O:Outgoing Correspondence |
| NOTICE OF CANCELLATION SEC. 8 EMAILED | 2021-10-05 | 46 NCS8 E:E-Mail |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 OPSUMIT 90653209 not registered Live/Pending |
Actelion Pharmaceuticals Ltd. 2021-04-18 |
 OPSUMIT 85727907 4589297 Live/Registered |
Actelion Pharmaceuticals Ltd 2012-09-13 |
 OPSUMIT 85329499 4056510 Live/Registered |
Actelion Pharmaceuticals Ltd 2011-05-25 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 